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Abstract
AIM
To investigate the repeatability of proton magnetic reson-
ance spectroscopy in the in vivo measurement of human 
cerebral levels of choline-containing compounds (Cho).
METHODS
Two consecutive scans were carried out in six healthy 
resting subjects at a magnetic field strength of 1.5 
T. On each occasion, neurospectroscopy data were 
collected from 64 voxels using the same 2D chemical 
shift imaging (CSI) sequence. The data were analyzed 
in the same way, using the same software, to obtain the 
values for each voxel of the ratio of Cho to creatine. The 
Wilcoxon related-samples signed-rank test, coefficient 
of variation (CV), repeatability coefficient (RC), and 
intraclass correlation coefficient (ICC) were used to 
assess the repeatability. 
RESULTS
The CV ranged from 2.75% to 33.99%, while the 
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minimum RC was 5.68%. There was excellent reproduci-
bility, as judged by significant ICC values, in 26 voxels. 
Just three voxels showed significant differences 
according to the Wilcoxon related-samples signed-rank 
test. 
CONCLUSION
It is therefore concluded that when CSI multivoxel 
proton neurospectroscopy is used to measure 
cerebral choline-containing compounds at 1.5 T, the 
reproducibility is highly acceptable.
Key words: Cerebral metabolites; Chemical shift 
imaging; Choline; Neurospectroscopy; Neuropsychiatric 
disorders
© The Author(s) 2018. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Proton neurospectroscopy is a powerful 
tool allowing the assessment of cerebral metabolites. 
As such, it is increasingly being introduced into 
the practice of psychiatry for the investigation of 
cerebral choline-containing compounds in patients, 
as well as being used as a research tool. However, 
it is important to establish the reproducibility of this 
sensitive technique. In the present study, we show 
that this technique (using 2D chemical shift imaging) 
gives a level of reproducibility that is highly acceptable. 
These results should further encourage the use of 
this technique, which, in principle, is available on all 
standard MRI scanners, in psychiatric practice.
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INTRODUCTION
In vivo magnetic resonance proton spectroscopy 
studies of the human brain pose a technical challenge 
given that the water signal is four orders of magnitude 
greater than signals from metabolites of interest, and 
also because of the narrow range of the chemical 
shift, spin-spin coupling complicating the spectral 
pattern, and the higher scalp lipid signal compared 
with cerebral metabolite signals; nevertheless, choline-
containing compounds (Cho) such as phosphoryl- and 
glycerophosphoryl-choline can be measured using this 
technique[1]. 
In contrast to the commonly used method of 
single-voxel spectroscopy (SVS), chemical shift 
imaging (CSI) is a multi-voxel technique. Thus, in 
neuroimaging, 2D-CSI has the distinct advantage over 
SVS of allowing larger areas of the brain to be studied 
during scanning, so that areas showing abnormal 
signals and also those appearing normal in structural 
magnetic resonance images can be included[2]. CSI can 
also be carried out in three dimensions, which should 
improve spatial resolution and the signal-to-noise 
ratio; however, 2D-CSI is more resistant to motion 
artefact, which can be a problem when scanning the 
brain, than 3D-CSI[3]. Furthermore, image quality is 
better with 2D-CSI compared with 3D-CSI at a usual 
magnetic field strength of 1.5 T or 3 T[4-6].
Choline is an alcohol which, in the human brain, 
is particularly abundant in phosphatidylcholine (in 
which it is attached, as a polar head group, via a 
phosphate group, to the Sn3 position of the glycerol 
backbone) membrane phospholipid molecules; Cho 
take part in membrane biosynthesis and breakdown[1]. 
Thus, measurement of Cho has clinical and research 
value. One example is in relation to chronic fatigue 
syndrome (also known as myalgic encephalomyelitis 
or systemic exertion intolerance disease), which is 
currently of unknown etiology. The first systematic 
proton neurospectroscopy study of this condition 
showed a significantly higher level of Cho in the 
occipital cortex in patients compared with matched 
healthy controls, and also loss of the spatial variation 
of Cho that is normally expected[7]. Given that 
such increased levels are associated with abnormal 
membrane phospholipid metabolism[8], this finding, 
which was essentially confirmed later by another 
group in respect of the basal ganglia[9], suggests that 
chronic fatigue syndrome/myalgic encephalomyelitis 
is associated with abnormal phospholipid metabolism 
in neuroglial membranes[1,7]. It has been suggested 
that this, in turn, might result from chronic viral 
infection[10]. Based on this Cho finding, a potential 
therapeutic approach to this difficult-to-treat disorder, 
involving long-chain polyunsaturated fatty acids, has 
been suggested[11,12]. A second example relates to 
dyslexia, which is another important neuropsychiatric 
disorder of unknown etiology, in which the first 
systematic proton neurospectroscopy study revealed 
decreased Cho in the left temporo-parietal lobe[13]. 
This finding could have resulted from reduced left 
temporo-parietal phospholipid metabolism[14], which 
would be consistent with the findings from the first 
systematic 31-phosphorus neurospectroscopy study of 
this disorder[15]. In turn, this has led to suggestions of 
potential therapeutic interventions[16].
2D-CSI may also be useful clinically in evaluating 
patients with acute onset of neuropsychiatric systemic 
lupus erythematosus[2]. Another important clinical use 
of 2D-CSI is in relation to grading gliomas when used 
in combination with diffusion kurtosis imaging and 
dynamic susceptibility-weighted contrast-enhanced 
MRI[17]. Indeed, in a brain histopathological study, it has 
been shown that 2D-CSI combined with perfusion MRI 
are associated with high sensibility and high specificity 
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in differentiating between glioblastoma multiforme and 
cerebral metastases and also in distinguishing between 
grade Ⅲ and grade Ⅳ gliomas[18]. It is therefore 
important to ascertain the reproducibility of 2D-CSI. 
We present the results of the first study to inves-
tigate the repeatability of proton magnetic resonance 
spectroscopy 2D-CSI in the in vivo measurement 
of human cerebral levels of Cho at a magnetic field 
strength of 1.5 T.
MATERIALS AND METHODS
Study design
This study was a repeated-measures pilot study in six 
individuals. The study was approved by the Research 
Ethics Committee. All participants gave written informed 
consent. Immediately after undergoing MRI scanning 
(including 2D-CSI), each participant remained lying in 
the scanner and the scanning protocol, including the 
2D-CSI, was repeated.
Volunteers
The cohort consisted of six healthy volunteers, three 
males and three females. Their mean age was 44.1 
years (range 26 to 58 years).
MR spectroscopy
All measurements were carried out using a 1.5-T 
Siemens Symphony TIM (Total Imaging Matrix) scanner 
(Siemens Medical Systems, Erlangen, Germany) using a 
standard head matrix coil. Proton spectra were acquired 
using a 64-voxel 2D-CSI spin-echo spectroscopy 
sequence with TE = 30 ms, TR = 1500 ms, number 
of averages = 4, field of view = 160 mm × 160 mm, 
and thickness = 15 mm. Figure 1 shows the location 
of the voxels. Spectral analysis was carried out using 
the Siemens spectroscopy task card (Siemens Medical 
Systems, Erlangen, Germany). This automated software 
analysis was objective and clearly obviated the need for 
inter-observer analysis.
Statistical analysis
The main endpoint of this study was the ratio of 
Cho to creatine (Cr) for each voxel. The coefficient 
of variation (CV), repeatability coefficient (RC), and 
intraclass correlation coefficient (ICC) were used to 
assess the repeatability. The repeatability coefficient 
was calculated as 1.96 × (standard deviation of the 
mean difference between two measurements), after 
the method proposed by Bland and Altman as being 
more appropriate than the correlation coefficient 
when assessing the level of agreement between two 
methods of clinical measurement[19]. The CV was 
calculated as (the standard deviation of the mean 
difference between two measurements)/(the mean 
of all measurements) and was assessed in order to 
allow comparison of the results of the present study 
with those of previous studies of the reproducibility 
of proton magnetic resonance (albeit without CSI). 
Differences between the results of the two scans were 
analyzed using the Wilcoxon related-samples signed-
rank test (a repeated-measures nonparametric test). 
A P-value of less than 0.05 was taken to be statistically 
significant. Statistical tests were carried out using the 
software package IBM SPSS Statistics for Windows, 
version 21 (IBM Corp., Armonk, NY, United States).
RESULTS
There were no technical difficulties in carrying out this 
study and all 2D-CSI proton neurospectroscopy data 
were included in the analyses. Figure 2 illustrates an 
example of a fitted spectrum from this study using the 
Siemens software.
The Wilcoxon related-samples signed-rank test 
results for all 64 voxels are shown in Table 1, using the 
voxel nomenclature given in Figure 1. Three voxels 
showed a significant difference between successive 
scans, namely voxels 3, 10 and 21. 
The values of the mean CV, RC and ICC (together 
with corresponding P values) are given in Table 2. The 
CV ranged from 2.75% (voxel 3) to 33.99% (voxel 
58). The minimum RC was 5.68% (voxel 3). Many of 
the ICC values were statistically significant, particularly 
for central and more caudal voxels, but also for some 
rostral voxels.
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Figure 1  Location and numbering of voxels.
Figure 2  A fitted 1H-MR spectrum.
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Table 1  Wilcoxon related-samples signed-rank test results
Voxel Median Cho/Cr 
at first scan
Median Cho/Cr 
at second scan
Wilcoxon related-
samples signed-rank 
test (P  value)
1 0.681 0.624 0.345
2 0.825 0.836 0.917
3 0.897 0.924 0.046
4 0.819 0.785 0.917
5 0.822 0.812 0.753
6 0.998 1.060 0.917
7 0.868 0.902 0.600
8 0.661 0.708 0.463
9 0.751 0.579 0.075
10 0.878 0.799 0.028
11 0.970 1.043 0.173
12 0.793 0.860 0.173
13 0.822 0.765 0.600
14 0.993 0.989 0.753
15 0.923 0.894 0.600
16 0.714 0.682 0.463
17 0.760 0.644 0.249
18 0.947 0.855 0.116
19 1.027 1.045 0.345
20 0.751 0.828 0.173
21 0.898 0.816 0.046
22 1.063 1.056 0.173
23 0.942 1.022 0.917
24 0.728 0.747 0.116
25 0.713 0.705 0.249
26 0.941 0.984 0.917
27 0.940 0.961 0.345
28 0.808 0.831 0.753
29 0.853 0.851 0.600
30 1.030 1.083 0.600
31 0.991 0.929 0.249
32 0.709 0.696 0.173
33 0.660 0.660 0.600
34 0.892 0.922 0.345
35 0.948 0.905 0.917
36 0.732 0.718 0.600
37 0.750 0.724 0.345
38 1.032 0.904 0.173
39 0.982 0.946 0.345
40 0.700 0.744 0.116
41 0.627 0.597 0.917
42 0.866 0.854 0.249
43 0.871 0.793 0.600
44 0.591 0.595 0.600
45 0.573 0.584 0.753
46 0.793 0.875 0.600
47 0.903 0.940 0.249
48 0.563 0.686 0.075
49 0.571 0.575 0.463
50 0.779 0.817 0.345
51 0.740 0.777 0.116
52 0.539 0.533 0.463
53 0.546 0.500 0.463
54 0.767 0.752 0.463
55 0.812 0.838 0.046
56 0.530 0.583 0.345
57 0.498 0.507 0.917
58 0.692 0.715 0.463
59 0.607 0.683 0.463
60 0.466 0.472 0.173
61 0.569 0.451 0.173
62 0.825 0.677 0.753
63 0.638 0.639 0.753
64 0.530 0.625 0.600
Table 2  Mean coefficient of variation, repeatability coefficient, 
and intraclass correlation coefficient for all voxels
Voxel Mean coefficient 
of variation
Repeatability 
coefficient
Intraclass correlation 
coefficient (P  value)
1 0.080 0.159    0.492 (0.236)
2 0.057 0.194    0.866 (0.032)
3 0.028 0.057         0.982 (< 0.0001)
4 0.115 0.386   -1.877 (0.822)
5 0.101 0.260   -0.066 (0.523)
6 0.117 0.446    0.372 (0.335)
7 0.053 0.171    0.829 (0.046)
8 0.076 0.206    0.158 (0.429)
9 0.191 0.607   -0.233 (0.612)
10 0.049 0.113    0.901 (0.003)
11 0.071 0.191    0.702 (0.081)
12 0.091 0.225    0.509 (0.197)
13 0.076 0.213    0.724 (0.100)
14 0.078 0.233    0.696 (0.124)
15 0.089 0.277    0.735 (0.105)
16 0.091 0.236   -0.024 (0.509)
17 0.290 1.287   -3.314 (0.949)
18 0.095 0.226    0.811 (0.029)
19 0.058 0.226    0.816 (0.052)
20 0.058 0.137    0.370 (0.273)
21 0.058 0.106    0.569 (0.071)
22 0.064 0.214    0.780 (0.048)
23 0.055 0.238    0.941 (0.005)
24 0.258 6.467  0.152 (0.43)
25 0.192 0.305    0.866 (0.028)
26 0.044 0.129    0.974 (0.001)
27 0.062 0.205    0.833 (0.033)
28 0.087 0.242    0.652 (0.159)
29 0.059 0.170    0.749 (0.088)
30 0.061 0.205    0.851 (0.034)
31 0.046 0.114       0.983 (< 0.001)
32 0.093 0.174    0.907 (0.007)
33 0.126 0.244    0.872 (0.024)
34 0.057 0.146    0.829 (0.033)
35 0.066 0.230    0.793 (0.071)
36 0.063 0.151    0.883 (0.024)
37 0.036 0.079    0.960 (0.002)
38 0.096 0.314    0.397 (0.284)
39 0.087 0.269   -0.162 (0.584)
40 0.122 0.222    0.643 (0.116)
41 0.185 0.225    0.917 (0.011)
42 0.055 0.138    0.950 (0.002)
43 0.083 0.235    0.691 (0.132)
44 0.106 0.217    0.553 (0.216)
45 0.106 0.369    0.229 (0.397)
46 0.182 0.547   -0.256 (0.588)
47 0.054 0.136    0.942 (0.003)
48 0.175 0.274   -0.074 (0.555) 
49 0.102 0.134    0.961 (0.002)
50 0.053 0.121    0.970 (0.001)
51 0.039 0.081    0.946 (0.001)
52 0.056 0.116  0.870 (0.03)
53 0.068 0.134    0.795 (0.064)
54 0.071 0.171    0.928 (0.007)
55 0.083 0.117    0.945 (0.001)
56 0.148 0.277    0.108 (0.448)
57 0.195 0.296    0.887 (0.022)
58 0.340 0.547    0.582 (0.188)
59 0.177 0.384  0.143 (0.43)
60 0.135 0.177    0.883 (0.011)
61 0.143 0.230    0.620 (0.135)
62 0.200 0.691    0.512 (0.253)
63 0.180 0.432    0.833 (0.046)
64 0.273 0.714 -0.957 (0.73)
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DISCUSSION
There have been no previous studies of the repeatability 
of proton neurospectroscopy 2D-CSI in the in vivo 
measurement of human cerebral levels of Cho at a 
magnetic field strength of 1.5 T. Previous in vivo studies 
of the reproducibility of proton magnetic resonance 
spectroscopy measurements have used single voxel 
techniques and have reported “within day” CV values 
for human hepatic fat of between 0.3% and 8.5%[20-25]. 
Thus the results of the present study compare favorably 
with these reports, which is all the more impressive 
given that cerebral tissue is more heterogeneous than 
hepatic tissue. There have been few cerebral single-
voxel proton reproducibility studies. Schirmer and Auer 
reported CVs for absolute human brain concentrations 
of the main metabolites Cho, Cr and N-acetylaspartate, 
ranging from 3.8% to 6.4%[26]; the present results 
compare very well with these. 
Van Werven and colleagues reported a “within 
day” RC value for hepatic fat (using a single voxel 
technique at 3 T) of 0.4%. Again, the present result 
of a minimum voxel RC of over 5% compares very 
well this result. Twenty-six of the voxels in the present 
study had an ICC which was statistically significant, 
indicating a high level of agreement for these voxels.
Just three voxels had median Cho to Cr ratios 
which were different between scans. From Figure 1 
it can be seen that these voxels (numbers 3, 10 and 
21) have locations in sulcal regions of the brain. It is 
therefore possible that the poor reproducibility in these 
three voxels might be a function of “bleeding” in the 
neurospectroscopy data acquisition. Voxel “bleeding” 
refers to contamination with signals derived from 
any of the six adjacent voxels, and is an analogue of 
artifactual Gibbs ringing in structural MRI[27]. In the 
present case, the contaminating signals could have 
arisen from the low-signal sulcal spaces.
In conclusion, in this first study of its type, the 
reproducibility of proton magnetic resonance spectro-
scopy in the in vivo measurement of human cerebral 
levels of Cho at a field strength of 1.5 T using 2D-CSI 
has been found to be very acceptable. These findings 
should further encourage the use of this technique in 
psychiatric clinical practice as well as in research studies 
of neuropsychiatric disorders. Already, neurospectroscopy 
is proving helpful in studies of schizophrenia, major 
depressive disorder, forensic psychiatry (e.g., 
posttraumatic stress disorder), chronic fatigue syndrome 
(myalgic encephalomyelitis or systemic exertion 
intolerance disease), and neuropsychiatric presentations 
in organic disorders, in which it has an important role to 
play in aiding diagnosis[16,28,29]. Given the present finding 
of a highly acceptable level of reproducibility of 2D-CSI, it 
would be appropriate in future to apply this technique to 
the follow-up of such patients, including monitoring their 
response to treatment.
ARTICLE HIGHLIGHTS
Research background
In vivo magnetic resonance proton spectroscopy studies of the brain can be 
used to measure Cho. In contrast to the commonly used method of SVS, CSI 
is a multi-voxel technique. Thus, compared with SVS, 2D-CSI allows larger 
areas of the brain to be studied, so that areas showing abnormal signals and 
also those appearing normal in structural MRI can be included. Compared with 
3D-CSI, 2D-CSI is more resistant to motion artefact, which can be a problem 
when scanning the brain, and image quality is better at a usual clinical magnetic 
field strength of 1.5 T or 3 T.
Research motivation
Brain choline is particularly abundant in phosphatidylcholine membrane phospholipid 
molecules; Cho take part in membrane biosynthesis and breakdown. Thus, measurement 
of Cho has clinical and research value. For example, in chronic fatigue syndrome (also 
known as myalgic encephalomyelitis or systemic exertion intolerance disease), which is 
of unknown etiology, the first systematic proton neurospectroscopy study showed 
a significantly higher level of Cho in the occipital cortex in patients compared 
with matched healthy controls, and also loss of the spatial variation of Cho 
that is normally expected. This finding, which was essentially confirmed later 
by another group in respect of the basal ganglia, suggests that this disorder is 
associated with abnormal phospholipid metabolism in neuroglial membranes 
and has led to the suggestion of a potential therapeutic approach. A second 
example is dyslexia, also of unknown etiology, in which the first systematic 
proton neurospectroscopy study revealed decreased Cho in the left temporo-
parietal lobe. This finding could have resulted from reduced left temporo-parietal 
phospholipid metabolism, which would be consistent with the findings from the 
first systematic 31-phosphorus neurospectroscopy study of dyslexia. In turn, this 
has led to suggestions of potential therapeutic interventions. 2D-CSI may also 
be useful clinically in evaluating patients with acute onset of neuropsychiatric 
symptoms. Another important clinical use of 2D-CSI is in relation to grading 
gliomas. It is therefore important to ascertain the reproducibility of 2D-CSI.
Research objective
The aim of this study was to investigate the repeatability of proton magnetic 
resonance spectroscopy 2D-CSI in the in vivo measurement of human cerebral 
levels of Cho.
Research methods
A repeated-measures study in six individuals was carried out using a 1.5-T 
Siemens Symphony TIM scanner and a standard head matrix coil. Proton 
spectra were acquired using a 64-voxel 2D-CSI spin-echo spectroscopy 
sequence. Spectral analysis was carried out using the Siemens spectroscopy 
task card. The main endpoint was the ratio of Cho to Cr for each voxel. The 
CV, RC, and ICC were used to assess the repeatability. There have been no 
previous studies of the repeatability of proton neurospectroscopy 2D-CSI in 
the in vivo measurement of human cerebral levels of Cho at a magnetic field 
strength of 1.5 T.
Research results
There was a minimum voxel RC of over 5%, which compared favorably with 
previous studies of the liver; the present results were all the more impressive 
given the much more heterogeneous nature of the brain compared with hepatic 
tissue. Twenty-six voxels had an ICC which was statistically significant, indicating 
a high level of agreement for these voxels. Just three voxels had median Cho to 
Cr ratios which were significantly different between scans. These three voxels 
were located in sulcal brain regions. Thus the poor reproducibility in these 
three voxels might be a function of “bleeding” in the neurospectroscopy data 
acquisition.
Research conclusions
In this first study of its type, the reproducibility of proton magnetic resonance 
spectroscopy in the in vivo measurement of human cerebral levels of Cho at 
a field strength of 1.5 T using 2D-CSI has been found to be very acceptable. 
Overall, the present findings should further encourage the use of this technique 
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in psychiatric clinical practice as well as in research studies of neuropsychiatric 
disorders.
Research perspectives
Overall, the results of this study are highly encouraging for the use of this 
technique in neuropsychiatric research and clinical practice. Further studies 
should be carried out to determine whether sulcal voxels should routinely be 
omitted from longitudinal comparison studies.
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